Vir Biotechnology, Inc. Shares Outstanding (Cover Page)
Vir Biotechnology, Inc. (VIR) had Shares Outstanding (Cover Page) of 169.22 million shares as of 2026-07-29, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-29: Entity Common Stock, Shares Outstanding 169.22M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 168.65M shares.
- 2026-02-17: Entity Common Stock, Shares Outstanding 139.52M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 139.13M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-29 | 169.22M shares 10-Q · filed 2026-08-05 |
| 2026-04-29 | 168.65M shares 10-Q · filed 2026-05-07 |
| 2026-02-17 | 139.52M shares 10-K · filed 2026-02-23 |
| 2025-10-29 | 139.13M shares 10-Q · filed 2025-11-05 |
| 2025-07-30 | 138.92M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 138.24M shares 10-Q · filed 2025-05-08 |
| 2025-02-20 | 137.14M shares 10-K · filed 2025-02-27 |
| 2024-10-25 | 137.72M shares 10-Q · filed 2024-11-04 |
| 2024-07-26 | 136.64M shares 10-Q · filed 2024-08-01 |
| 2024-04-26 | 136.06M shares 10-Q · filed 2024-05-03 |
| 2024-02-16 | 135.03M shares 10-K · filed 2024-02-26 |
| 2023-10-27 | 134.52M shares 10-Q · filed 2023-11-03 |
| 2023-07-28 | 134.25M shares 10-Q · filed 2023-08-04 |
| 2023-05-01 | 133.98M shares 10-Q · filed 2023-05-08 |
| 2023-02-21 | 133.53M shares 10-K · filed 2023-02-28 |
| 2022-10-31 | 133.12M shares 10-Q · filed 2022-11-03 |
| 2022-08-01 | 132.64M shares 10-Q · filed 2022-08-09 |
| 2022-05-02 | 132.38M shares 10-Q · filed 2022-05-05 |
| 2022-02-22 | 132.30M shares 10-K · filed 2022-02-28 |
| 2021-11-01 | 130.88M shares 10-Q · filed 2021-11-04 |
| 2021-08-02 | 130.61M shares 10-Q · filed 2021-08-05 |
| 2021-05-03 | 130.04M shares 10-Q · filed 2021-05-06 |
| 2021-02-22 | 127.84M shares 10-K · filed 2021-02-25 |
| 2020-11-06 | 127.39M shares 10-Q · filed 2020-11-10 |
| 2020-08-07 | 127.05M shares 10-Q · filed 2020-08-11 |
| 2020-05-08 | 117.90M shares 10-Q · filed 2020-05-12 |
| 2020-03-23 | 109.80M shares 10-K · filed 2020-03-26 |
| 2019-11-15 | 109.68M shares 10-Q · filed 2019-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |